Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. 1993

R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee.

Bis(pivaloyloxymethyl) [bis(pom)] derivatives of various acyclic nucleoside phosphonates--9-(2-phosphonylmethoxyethyl)adenine (PMEA), 9-(2-phosphonylmethoxypropyl)adenine (PMPA), and 9-(2-phosphonylmethoxypropyl)diaminopurine (PMPDAP)--were found to exhibit 9- to 23-fold greater antiviral activity than their corresponding unmodified compounds. The cytotoxicity of the bis(pom) analogs was also increased by various degrees, thus altering the therapeutic indexes of these compounds. Metabolic studies using [3H]bis(pom)PMEA and [3H]PMEA as model compounds suggested a > 100-fold increase in the cellular uptake of the bis(pom) derivative and formation of active diphosphorylated metabolite. However, the bis(pom) derivatives were chemically unstable and highly susceptible to serum-mediated hydrolysis, factors which limit their potential utility for intracellular drug delivery.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D005110 Extracellular Space Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall. Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
February 2005, The Journal of infectious diseases,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
November 2021, Journal of medicinal chemistry,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
April 1995, Molecular pharmacology,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
September 2017, Bioorganic & medicinal chemistry,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
September 2011, European journal of medicinal chemistry,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
October 2005, Current protocols in nucleic acid chemistry,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
September 2012, European journal of medicinal chemistry,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
January 2011, Phosphorus, sulfur, and silicon and the related elements,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
November 2007, European journal of pharmacology,
R V Srinivas, and B L Robbins, and M C Connelly, and Y F Gong, and N Bischofberger, and A Fridland
July 1997, Molecular pharmacology,
Copied contents to your clipboard!